OR51E2 and asthma: OR51E2 has been shown to modulate proliferation and cytoskeletal remodeling in ASM from both asthmatics and non-asthmatics, implying that modulation of OR51E2 signaling may be beneficial in asthma (Aisenberg et al., 2016).